1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
The Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined With Obinutuzumab in MCLIntermediate-to-High-Risk Mantle Cell Lymphoma; the Efficacy and SafetyNot yet recruitingPhase 12026-04-23NCT07548255